Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function
- PMID: 34288397
- PMCID: PMC8419180
- DOI: 10.1111/jcmm.16740
Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function
Abstract
N6-Methyladenosine (m6A) is the most prevalent internal modification in messenger RNAs (mRNAs) of eukaryotes and plays a vital role in post-transcriptional regulation. Recent studies demonstrated that m6A is essential for the normal function of the central nervous system (CNS), and the deregulation of m6A leads to a series of CNS diseases. However, the functional consequences of m6A deficiency within the dopaminergic neurons of adult brain are elusive. To evaluate the necessity of m6A in dopaminergic neuron functions, we conditionally deleted Mettl14, one of the most important part of m6A methyltransferase complexes, in the substantia nigra (SN) region enriched with dopaminergic neurons. By using rotarod test, pole test, open-field test and elevated plus maze, we found that the deletion of Mettl14 in the SN region induces impaired motor function and locomotor activity. Further molecular analysis revealed that Mettl14 deletion significantly reduced the total level of m6A in the mRNA isolated from SN region. Tyrosine hydroxylase (TH), an essential enzyme for dopamine synthesis, was also down-regulated upon Mettl14 deletion, while the activation of microglia and astrocyte was enhanced. Moreover, the expression of three essential transcription factors in the regulation of TH including Nurr1, Pitx3 and En1, with abundant m6A-binding sites on their RNA 3'-untranslated regions (UTR), was significantly decreased upon Mettl14 deletion in SN. Our finding first confirmed the significance of m6A in maintaining normal dopaminergic function in the SN of adult mouse.
Keywords: Mettl14; dopaminergic neuron; m6A; tyrosine hydroxylase.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors confirm that there are no conflicts of interest.
Figures
Similar articles
-
Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.BMC Biol. 2022 Jun 13;20(1):140. doi: 10.1186/s12915-022-01335-x. BMC Biol. 2022. PMID: 35698136 Free PMC article.
-
The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.J Cell Biochem. 2020 Jan;121(1):524-533. doi: 10.1002/jcb.29258. Epub 2019 Jul 18. J Cell Biochem. 2020. PMID: 31318098
-
METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.Mol Med. 2021 Sep 9;27(1):106. doi: 10.1186/s10020-021-00365-5. Mol Med. 2021. PMID: 34503454 Free PMC article.
-
The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer.Mol Cancer. 2022 Aug 16;21(1):163. doi: 10.1186/s12943-022-01634-5. Mol Cancer. 2022. PMID: 35974338 Free PMC article. Review.
-
Insights into roles of METTL14 in tumors.Cell Prolif. 2022 Jan;55(1):e13168. doi: 10.1111/cpr.13168. Epub 2021 Dec 13. Cell Prolif. 2022. PMID: 34904301 Free PMC article. Review.
Cited by
-
Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.Mol Biol Rep. 2024 Feb 24;51(1):347. doi: 10.1007/s11033-024-09294-y. Mol Biol Rep. 2024. PMID: 38400887 Review.
-
Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome.Int J Mol Sci. 2023 Sep 9;24(18):13897. doi: 10.3390/ijms241813897. Int J Mol Sci. 2023. PMID: 37762200 Free PMC article. Review.
-
The RNA m6A modification might participate in microglial activation during hypoxic-ischemic brain damage in neonatal mice.Hum Genomics. 2023 Aug 25;17(1):78. doi: 10.1186/s40246-023-00527-y. Hum Genomics. 2023. PMID: 37626401 Free PMC article.
-
In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases.Neurol Int. 2023 Aug 10;15(3):967-979. doi: 10.3390/neurolint15030062. Neurol Int. 2023. PMID: 37606395 Free PMC article. Review.
-
Upregulation of UBR1 m6A Methylation by METTL14 Inhibits Autophagy in Spinal Cord Injury.eNeuro. 2023 Jun 2;10(6):ENEURO.0338-22.2023. doi: 10.1523/ENEURO.0338-22.2023. Print 2023 Jun. eNeuro. 2023. PMID: 37094938 Free PMC article.
References
-
- Livneh I, Moshitch‐Moshkovitz S, Amariglio N, Rechavi G, Dominissini D. The m(6)A epitranscriptome: transcriptome plasticity in brain development and function. Nat Rev Neurosci. 2020;21:36‐51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
